Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;34(12):e14057.
doi: 10.1111/pai.14057.

Omalizumab in severe asthma and food allergies with IgE levels >1500 kU/L: Two-year evaluation

Affiliations

Omalizumab in severe asthma and food allergies with IgE levels >1500 kU/L: Two-year evaluation

Giulio Dinardo et al. Pediatr Allergy Immunol. 2023 Dec.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Menzella F, Just J, Sauerbeck IS, et al. Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL. World Allergy Organ J. 2023;16(6):100787. doi:10.1016/j.waojou.2023.100787
    1. Johansson SGO, Haahtela T, O'Byrne PM. Omalizumab and the immune system: an overview of preclinical and clinical data. Ann Allergy Asthma Immunol. 2002;89(2):132-138. doi:10.1016/S1081-1206(10)61928-X
    1. Molderings GJ, Dumoulin FL, Homann J, et al. Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(9):1573-1580. doi:10.1007/S00210-020-01886-2
    1. Dahdah L, Ceccarelli S, Amendola S, et al. IgE Immunoadsorption knocks down the risk of food-related anaphylaxis. Pediatrics. 2015;136(6):e1617-e1620. doi:10.1542/PEDS.2015-1757
    1. Arasi S, Piscitelli AL, Cafarotti A, et al. IgE-immunoadsorption for severe allergy to multiple foods: a case series of five children. World Allergy Organ J. 2023;16(2):100750. doi:10.1016/J.WAOJOU.2023.100750

MeSH terms